Üstündağ Medine Gözde, Beyhun Nazım Ercüment, Topbaş Murat, Turhan Sevil
Kars Provincial Health Directorate, Public Health Services, Kars, Türkiye.
Department of Public Health, Karadeniz Technical University Faculty of Medicine, Trabzon, Türkiye.
PLoS One. 2025 Apr 7;20(4):e0319762. doi: 10.1371/journal.pone.0319762. eCollection 2025.
The aim of this study is to determine the direct medical costs of adult cases diagnosed with Covid-19 and hospitalized at Karadeniz Technical University Faculty of Medicine Farabi Hospital (KTUFMFH).
This is a cost of illness study. The direct medical costs of adult cases who were hospitalized and treated for Covid-19 at KTUFMFH between 13.03.2020-12.03.2021 were examined. The study was retrospectively, on hospital perspective, using a prevalence-based approach and a bottom-up costing method. Per case costs, distribution of costs, and factors were examined for 113 cases. The determinants of the costs were evaluated via logistic regression analysis.
The median cost per case was 263.55 (min: 28.30 - max: 18,947.60) USD [229.55 (min: 23.90 - max: 15,633.67) EUR]. One-day increase in hospitalization (O.R. = 2.600 and %95 C.I. = 1.576-4.289), the presence of chronic disease (O.R. = 15.130 and %95 C.I. = 1.644-139.216) and receiving oxygen inhalation therapy (O.R. = 15.238 and %95 C.I. = 1.784-130.157) have been identified to increase medical cost of Covid-19 inpatients.
Covid-19 hospital costs are of significant economic burden. The actions in order to lower the severity of the disease may play role to lower the medical costs in future coronavirus related pandemics.
本研究旨在确定在特拉布宗技术大学医学院法拉比医院（KTUFMFH）确诊并住院的成年新冠肺炎病例的直接医疗费用。
这是一项疾病成本研究。对2020年3月13日至2021年3月12日期间在KTUFMFH因新冠肺炎住院治疗的成年病例的直接医疗费用进行了检查。该研究采用基于患病率的方法和自下而上的成本核算方法，从医院角度进行回顾性研究。对113例病例的每例成本、成本分布和影响因素进行了检查。通过逻辑回归分析评估成本的决定因素。
每例病例的中位数成本为263.55美元（最小值：28.30 - 最大值：18,947.60美元）[229.55欧元（最小值：23.90 - 最大值：15,633.67欧元）]。住院时间每增加一天（比值比 = 2.600，95%置信区间 = 1.576 - 4.289）、存在慢性病（比值比 = 15.130，95%置信区间 = 1.644 - 139.216）和接受吸氧治疗（比值比 = 15.238，95%置信区间 = 1.784 - 130.157）已被确定会增加新冠肺炎住院患者的医疗成本。
新冠肺炎住院费用构成了巨大的经济负担。降低疾病严重程度的措施可能在未来与冠状病毒相关的大流行中起到降低医疗成本的作用。
